CARIBOU BIOSCIENCES INC. - COMMON STOCK

Caribou Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update

09 Aug 2022 13:00:00 By Nasdaq GlobeNewswire

Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress

10 Jun 2022 00:00:00 By Nasdaq GlobeNewswire

Caribou Biosciences Announces Webcast Conference Call to Highlight Initial CB-010 ANTLER Phase 1 Data Presentation at EHA on June 10, 2022

01 Jun 2022 13:05:00 By Nasdaq GlobeNewswire

Caribou Biosciences Presents Data on Mechanism Underlying Superior Specificity of Caribou’s chRDNA Genome-Editing Technology in Primary Human T cells

16 May 2022 13:05:01 By Nasdaq GlobeNewswire

Caribou Biosciences Announces Positive Initial Data for CB-010 Anti-CD19 Allogeneic CAR-T Cell Therapy

12 May 2022 07:00:00 By Nasdaq GlobeNewswire

Caribou Biosciences Announces Appointment of David Johnson to its Board of Directors

11 May 2022 13:00:00 By Nasdaq GlobeNewswire

Caribou Biosciences Reports First Quarter 2022 Financial Results and Provides Business Updates

09 May 2022 13:05:01 By Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conference

03 May 2022 13:05:00 By Nasdaq GlobeNewswire

Caribou Biosciences to Share CB-010 Initial Clinical Data at the Upcoming European Hematology Association (EHA) 2022 Hybrid Congress

25 Apr 2022 13:05:00 By Nasdaq GlobeNewswire

Caribou Biosciences Presents Positive Preclinical Data for Allogeneic Anti-BCMA CAR-T Cell Therapy Candidate CB-011 at the American Association for Cancer Research (AACR) Annual Meeting

08 Apr 2022 10:07:17 By Nasdaq GlobeNewswire

Caribou Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

21 Mar 2022 13:02:00 By Nasdaq GlobeNewswire

Caribou Biosciences to Present Preclinical Data on CB-011, an Immune-Cloaked Allogeneic Anti-BCMA CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting

08 Mar 2022 17:19:17 By Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

07 Mar 2022 13:10:57 By Nasdaq GlobeNewswire

Caribou Biosciences to Present at the SVB Leerink 11th Annual Global Healthcare Conference

07 Feb 2022 13:05:00 By Nasdaq GlobeNewswire

Caribou Biosciences Appoints Syed Rizvi, M.D., as Chief Medical Officer

18 Jan 2022 05:00:02 By Nasdaq GlobeNewswire

Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference

04 Jan 2022 13:05:00 By Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

17 Nov 2021 13:05:00 By Nasdaq GlobeNewswire

Caribou Biosciences Provides Business Update and Reports Third Quarter 2021 Financial Results

09 Nov 2021 13:05:03 By Nasdaq GlobeNewswire

Caribou Biosciences Appoints Dara Richardson-Heron, M.D., to its Board of Directors and Ruhi Khan as Chief Business Officer

08 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

Caribou Biosciences to Present at Upcoming Investor Conferences

20 Oct 2021 13:00:00 By Nasdaq GlobeNewswire